UnitedHealthcare
teriparatide (teriparatide)
Hormones : Drugs for Menopause and Bone Loss
  • Prior Authorization: Osteoporosis: Post Menopausal Women:
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Duration: 24 Month(s)
    Reauthorization Required: Yes

  • Step Therapy: Osteoporosis: Post Menopausal Women:
    ST Single Generic

  • Osteoporosis: Post Menopausal Women:
    Duration: 24 Month(s)
    Medical Test Required: Yes
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    History of Fracture Required: Variable
    USA specific WHO fracture (FRAX) assessment criteria positive: Variable
    BMD T-score at neck, total hip, or lumbar spine: <= -4
    Self-Administration Allowed: No
    Multiple fractures required: Yes
    Documented Diagnosis: Yes